| 1 | delineating the molecular and | | | | | | | 2 | 0.36% |
| 2 | underlying pathophysiology of disease | | | | | | | 2 | 0.36% |
| 3 | 1920x600 previous arrowprevious arrow | | | | | | | 2 | 0.36% |
| 4 | previous arrowprevious arrow next | | | | | | | 2 | 0.36% |
| 5 | the molecular and cellular | | | | | | | 2 | 0.36% |
| 6 | logo 1920x600 countries 1920x600 | | | | | | | 2 | 0.36% |
| 7 | questions a special focus | | | | | | | 1 | 0.18% |
| 8 | and tissues to solve | | | | | | | 1 | 0.18% |
| 9 | tissues to solve important | | | | | | | 1 | 0.18% |
| 10 | research questions a special | | | | | | | 1 | 0.18% |
| 11 | ga naar de inhoud | | | | | | | 1 | 0.18% |
| 12 | a special focus will | | | | | | | 1 | 0.18% |
| 13 | special focus will be | | | | | | | 1 | 0.18% |
| 14 | on cells and tissues | | | | | | | 1 | 0.18% |
| 15 | focus will be the | | | | | | | 1 | 0.18% |
| 16 | will be the acquisition | | | | | | | 1 | 0.18% |
| 17 | cells and tissues to | | | | | | | 1 | 0.18% |
| 18 | and petmri imaging on | | | | | | | 1 | 0.18% |
| 19 | imaging on cells and | | | | | | | 1 | 0.18% |
| 20 | petmri imaging on cells | | | | | | | 1 | 0.18% |
| 21 | microscopy and petmri imaging | | | | | | | 1 | 0.18% |
| 22 | sequencing metabolomics cytof advanced | | | | | | | 1 | 0.18% |
| 23 | cell sequencing metabolomics cytof | | | | | | | 1 | 0.18% |
| 24 | single cell sequencing metabolomics | | | | | | | 1 | 0.18% |
| 25 | eg single cell sequencing | | | | | | | 1 | 0.18% |
| 26 | technologies eg single cell | | | | | | | 1 | 0.18% |
| 27 | basic microscopy and stateoftheart | | | | | | | 1 | 0.18% |
| 28 | culture basic microscopy and | | | | | | | 1 | 0.18% |
| 29 | cell culture basic microscopy | | | | | | | 1 | 0.18% |
| 30 | be the acquisition processing | | | | | | | 1 | 0.18% |
| 31 | use of human biosamples | | | | | | | 1 | 0.18% |
| 32 | and use of human | | | | | | | 1 | 0.18% |
| 33 | obtained data to setup | | | | | | | 1 | 0.18% |
| 34 | important in this era | | | | | | | 1 | 0.18% |
| 35 | increasingly important in this | | | | | | | 1 | 0.18% |
| 36 | becomes increasingly important in | | | | | | | 1 | 0.18% |
| 37 | disease the third pillar | | | | | | | 1 | 0.18% |
| 38 | of disease the third | | | | | | | 1 | 0.18% |
| 39 | pathophysiology of disease the | | | | | | | 1 | 0.18% |
| 40 | at delineating the molecular | | | | | | | 1 | 0.18% |